Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 12 de 12
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Sci Rep ; 14(1): 2816, 2024 02 02.
Article de Anglais | MEDLINE | ID: mdl-38307935

RÉSUMÉ

Neuroendocrine prostate cancer (NEPC) is a highly lethal variant of castration-resistant prostate cancer (CRPC) with poor survival rates. Current treatment options for NEPC are limited to highly toxic platinum drugs highlighting the urgent need for new therapies. This study aimed to develop a novel therapeutic approach using engineered exosomes against NEPC. Exosomes were modified to target CEACAM5, an NEPC surface antigen, by attaching CEACAM5 antibodies to HEK293T exosomes. These exosomes were loaded with drugs inhibiting EZH2 and the androgen receptor (AR) as recent research shows a persistent role of AR in NEPC wherein it plays a concerted role with EZH2 in driving neuronal gene programs. In vitro experiments with NEPC cell lines demonstrated that CEACAM5-targeted exosomes were specifically taken up by NEPC cells, leading to reduced cellular viability and decreased expression of neuronal markers. Further in vivo tests using a NEPC patient-derived xenograft model (LuCaP145.1) showed significant tumor regression in mice treated with engineered exosomes compared to control mice receiving IgG-labeled exosomes. These results suggest that CEACAM5-engineered exosomes hold promise as a targeted therapy for NEPC. Importantly, our exosome engineering strategy is versatile and can be adapted to target various surface antigens in prostate cancer and other diseases.


Sujet(s)
Exosomes , Tumeurs de la prostate , Mâle , Humains , Animaux , Souris , Exosomes/métabolisme , Cellules HEK293 , Tumeurs de la prostate/traitement médicamenteux , Tumeurs de la prostate/génétique , Lignée cellulaire tumorale
2.
Eur J Nutr ; 62(7): 3033-3054, 2023 Oct.
Article de Anglais | MEDLINE | ID: mdl-37493680

RÉSUMÉ

PURPOSE: The leaky gut barrier is an important factor leading to various inflammatory gastrointestinal disorders. The nutritional value of honey and variety of its health benefits have long been recognized. This study was undertaken to assess the role of Indian mustard honey in preventing lipopolysaccharide (LPS)-induced intestinal barrier dysfunction using a combination of in vitro and in vivo experimental model systems. METHODS: LPS was used to induce intestinal barrier damage in a trans-well model of Caco-2 cells (1 µg/ml) and in Swiss albino mice (5 mg/kg body weight). Gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-mass spectrometry (LC-MS) were used to analyse sugar and phenolic components in honey samples. The Caco-2 cell monolayer integrity was evaluated by transepithelial electrical resistance (TEER) and paracellular permeability assays. The histopathology of intestinal tissue was analysed by haematoxylin and eosin dual staining. The quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was used to quantify the transcription of genes. The protein expression was analysed by immunofluorescence, western blot and ELISA-based techniques. RESULTS: The in vitro data showed that honey prevented LPS-induced intestinal barrier dysfunction dose dependently as was measured by TEER and paracellular flux of FITC-dextran dye. Further, the in vivo data showed a prophylactic effect of orally administered honey as it prevented the loss of intestinal barrier integrity and villus structure. The cellular localization and expression of tight junction (TJ) proteins were upregulated along with downregulation of pro-inflammatory cytokines in response to the administration of honey with LPS. CONCLUSIONS: The findings of this study suggest a propitious role of honey in the maintenance of TJ protein integrity, thereby preventing LPS-induced intestinal barrier disintegration.


Sujet(s)
Maladies gastro-intestinales , Miel , Maladies intestinales , Humains , Souris , Animaux , Cellules Caco-2 , Protéines de la jonction serrée/génétique , Protéines de la jonction serrée/métabolisme , Régulation positive , Lipopolysaccharides/métabolisme , Jonctions serrées/métabolisme , Maladies gastro-intestinales/métabolisme , Maladies gastro-intestinales/anatomopathologie , Muqueuse intestinale/métabolisme , Perméabilité
3.
Biol Trace Elem Res ; 201(8): 3755-3773, 2023 Aug.
Article de Anglais | MEDLINE | ID: mdl-36394793

RÉSUMÉ

It is now widely accepted that anti-cancer medications are most effective when administered in combination. Zinc is an essential micronutrient whilst berberine is a well-known natural phytochemical, both having multiple molecular mechanisms of action. The present study aimed to determine the combinatorial effect of zinc and berberine on the human adenocarcinoma HT-29 cancer cell line. The anti-proliferative activity of berberine and zinc was determined by cell viability and colony-forming assays. The combination index and drug reduction index values of zinc and berberine co-treatments were estimated by suitable software. Flow cytometry was used to analyse cell cycle distribution and Annexin V/PI staining. The expression of apoptosis and zinc signalling markers were analysed by RT-qPCR and immunoblot analysis. Berberine decreased the viability of colon cancer cells in a dose-dependent manner whilst zinc alone had no significant influence on it. However, zinc and berberine co-treatment resulted in a synergistic anti-cancer action which was demonstrated by G2/M phase arrest of cell growth at a lower dose of berberine. Annexin V assay demonstrated that the synergistic impact of zinc and berberine boosted the number of apoptotic cells. Gene expression analysis at both transcriptional and translational levels showed the upregulation of apoptotic (caspase-3 and caspase-8) and a zinc-sensing receptor (GPR39) gene with concomitant downregulation of anti-apoptotic genes like proliferating cell nuclear antigen (PCNA) and clusterin. Our findings showed that the combination of zinc and berberine has synergistic anti-cancer efficacy and thus could be used as a potential chemopreventive option for colon cancer.


Sujet(s)
Berbérine , Tumeurs du côlon , Tumeurs colorectales , Humains , Berbérine/pharmacologie , Berbérine/usage thérapeutique , Zinc/pharmacologie , Clusterine/pharmacologie , Annexine A5/pharmacologie , Lignée cellulaire tumorale , Apoptose , Prolifération cellulaire , Tumeurs du côlon/traitement médicamenteux , Tumeurs colorectales/traitement médicamenteux , Récepteurs couplés aux protéines G
4.
Cancers (Basel) ; 16(1)2023 Dec 21.
Article de Anglais | MEDLINE | ID: mdl-38201476

RÉSUMÉ

The molecular basis of prostate cancer (PCa) progression from the primary disease to metastatic castration-resistant prostate cancer (CRPC) followed by therapy-induced neuroendocrine prostate cancer is not fully understood. In this study, we elucidate the role of miR-410, a little-studied microRNA located on chromosome 14q32.31 within the DLK1-DIO3 cluster, in PCa. miR-410 expression analyses in primary and metastatic PCa tissues and cell lines show that its levels are decreased in initial stages and increased in advanced PCa. Functional studies were performed in a series of PCa cell lines. In LNCaP cells, miR-410 overexpression led to decreases in cellular viability, proliferation, invasiveness, and migration. On the other hand, miR-410 overexpression in PC3 and C42B cells led to increased viability, proliferation, and invasiveness. Our data suggest that miR-410 represses epithelial-to-mesenchymal transition (EMT) in LNCaP cells by directly repressing SNAIL. However, it promotes EMT and upregulates PI3K/Akt signaling in PC3 and C42B cells. In vivo studies with PC3 xenografts support an oncogenic role of miR-410. These data suggest that miR-410 acts as a tumor suppressor in the initial stages of PCa and play an oncogenic role in advanced PCa. Our findings have important implications in understanding the molecular basis of PCa progression with potential translational implications.

5.
Food Funct ; 13(16): 8474-8488, 2022 Aug 15.
Article de Anglais | MEDLINE | ID: mdl-35861716

RÉSUMÉ

The rich and diverse phytoconstituents of wheatgrass have established it as a natural antioxidant and detoxifying agent. The anti-inflammatory potential of wheatgrass has been studied extensively. However, the neuroprotective potential of wheatgrass has not been studied in depth. In this study, we investigated the neuroprotective response of wheatgrass against age-related scopolamine-induced amnesia in mice. Scopolamine is an established anticholinergic drug that demonstrates the behavioural and molecular characteristics of Alzheimer's disease. In the current study, wheatgrass extracts (prepared from 5 and 7 day old plantlets) were administered to scopolamine-induced memory deficit mice. The Morris water maze (MWM) and Y-maze tests demonstrated that wheatgrass treatment improves the behavior and simultaneously enhances the memory of amnesic mice. We further evaluated the expression of neuroinflammation related genes and proteins in the hippocampal region of mice. Wheatgrass significantly upregulated the mRNA and protein expression of neuroprotective markers such as BDNF and CREB in scopolamine-induced mice. Simultaneously, wheatgrass also downregulated the expression of inflammatory markers such as TNF-α and tau genes in these mice. The treatment of scopolamine-induced memory impaired mice with wheatgrass resulted in an elevation in the level of the phosphorylated form of ERK and Akt proteins. Wheatgrass treatment of mice also regulated the phosphorylation of tau protein and simultaneously prevented its aggregation in the hippocampal region of the brain. Overall, this study suggests the therapeutic potential of wheatgrass in the treatment of age-related memory impairment, possibly through the involvement of ERK/Akt-CREB-BDNF pathway and concomitantly ameliorating the tau-related pathogenesis.


Sujet(s)
Neuroprotecteurs , Scopolamine , Acetylcholinesterase/métabolisme , Amnésie/induit chimiquement , Amnésie/traitement médicamenteux , Amnésie/métabolisme , Animaux , Facteur neurotrophique dérivé du cerveau/génétique , Facteur neurotrophique dérivé du cerveau/métabolisme , Hippocampe/métabolisme , Apprentissage du labyrinthe , Troubles de la mémoire/traitement médicamenteux , Souris , Neuroprotecteurs/usage thérapeutique , Extraits de plantes/métabolisme , Protéines proto-oncogènes c-akt/métabolisme , Scopolamine/effets indésirables , Scopolamine/métabolisme
6.
Curr Res Toxicol ; 3: 100072, 2022.
Article de Anglais | MEDLINE | ID: mdl-35633890

RÉSUMÉ

Triclosan (TCS) is widely used in cosmetics and healthcare industry as a broad-spectrum antibacterial agent. The lipophilic property and persistent nature of TCS has led to severe health issues. In the present study, we have evaluated the neuroinflammatory effect of TCS on mouse Neuro-2a cells. Initial investigation confirmed a dose-dependent loss in viability and morphology of cells in presence of TCS. The transcription and translation studies confirmed a downregulation in the expression of autophagy markers in Neuro-2a cells. The confocal microscopy study revealed that the abrogated autophagy in TCS-treated cells occurred due to loss in the autophagy flux and prevention in the lipidation of autophagosome bilayer. The fluorescence microscopy also confirmed a loss in the formation of autophagolysosomes in neuronal cells with increasing TCS concentrations. TCS treatment resulted in loss of mitochondrial integrity in cells as evidenced by a decrease in mitochondrial membrane potential in JC-1 staining. Further, the transcriptional and translational studies confirmed the activation of TNF-α signaling pathway in TCS-treated cells thus enhancing the expression of RIPK1, RIPK3 and MLKL proteins and their phosphorylated forms. TCS was also found to increase the tau protein pathogenesis in Neuro-2a cells, which alludes to the development of tau-associated neurodegeneration. Altogether, this study confirms the neuroinflammatory actions of TCS in Neuro-2a cells involving a TNF-α-induced MLKL-mediated signaling.

7.
Curr Res Toxicol ; 2: 116-127, 2021.
Article de Anglais | MEDLINE | ID: mdl-34345856

RÉSUMÉ

Inflammation is a multifaceted set of cellular communications generated against foreign infection, toxic influence or autoimmune injury. The present study investigates the anti-inflammatory effect of wheatgrass extract against the harmful impact of lipopolysaccharide (LPS) in macrophage cells, i.e., RAW 264.7 cells. Our results indicate that 5- and 7- days old wheatgrass extracts inhibit the LPS-stimulated production of nitric oxide. Moreover, wheatgrass extract significantly downregulates the mRNA expression of LPS-stimulated various pro-inflammatory markers, tumor necrosis factor-α, interleukin-6, interleukin-1ß, AP-1 and also iNOS-2 and COX-2. Our flow cytometry analyses confirmed that wheatgrass extract prevents the generation of reactive oxygen species in LPS-stimulated RAW 264.7 cells, thus arresting oxidative stress in cells. The immunoblot analyses also confirmed a significant reduction in the expression of inflammatory proteins, namely, iNOS-2 and COX-2, in wheatgrass extract-treated cells, compared to LPS-stimulated condition. The NF-κB transactivation assay further confirmed the inhibitory effect of wheatgrass extracts on the LPS-stimulated expression of NF-κB. Molecular docking based studies showed the plausible binding of two significant wheatgrass constituents, i.e., apigenin and myo-inositol with COX-2 protein, with binding energies of -10.59 kcal/mol and -7.88 kcal/mol, respectively. Based on the above results, wheatgrass may be considered as a potential therapeutic candidate for preventing inflammation.

8.
Front Chem ; 9: 639090, 2021.
Article de Anglais | MEDLINE | ID: mdl-33937192

RÉSUMÉ

Green synthesis of gold-zinc oxide (Au-ZnO) nanocomposite was successfully attempted under organic solvent-free conditions at room temperature. Prolonged stirring of the reaction mixture introduced crystallinity in the ZnO phase of Au-ZnO nanocomposites. Luminescence properties were observed in these crystalline Au-ZnO nanocomposites due to in situ embedding of gold nanoparticles (AuNP) of 5-6 nm diameter on the surface. This efficient strategy involved the reduction of Au(III) by Zn(0) powder in aqueous medium, where sodium citrate (NaCt) was the stabilizing agent. Reaction time and variation of reagent concentrations were investigated to control the Au:Zn ratio within the nanocomposites. The reaction with the least amount of NaCt for a long duration resulted in Au-ZnO/Zn(OH)2 nanocomposite. X-ray photoelectron spectroscopy (XPS) confirmed the formation of Zn(OH)2 and ZnO in the same nanocomposite. These nanocomposites were reconnoitered as bioimaging materials in human cells and applied for visible light-induced photodegradation of rhodamine-B dye.

9.
Stem Cell Rev Rep ; 17(1): 94-112, 2021 02.
Article de Anglais | MEDLINE | ID: mdl-33029768

RÉSUMÉ

Coronavirus disease 2019 (COVID-19) is caused by novel coronavirus Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It was first time reported in December 2019 in Wuhan, China and thereafter quickly spread across the globe. Till September 19, 2020, COVID-19 has spread to 216 countries and territories. Severe infection of SARS-CoV-2 cause extreme increase in inflammatory chemokines and cytokines that may lead to multi-organ damage and respiratory failure. Currently, no specific treatment and authorized vaccines are available for its treatment. Renin angiotensin system holds a promising role in human physiological system specifically in regulation of blood pressure and electrolyte and fluid balance. SARS-CoV-2 interacts with Renin angiotensin system by utilizing angiotensin-converting enzyme 2 (ACE2) as a receptor for its cellular entry. This interaction hampers the protective action of ACE2 in the cells and causes injuries to organs due to persistent angiotensin II (Ang-II) level. Patients with certain comorbidities like hypertension, diabetes, and cardiovascular disease are under the high risk of COVID-19 infection and mortality. Moreover, evidence obtained from several reports also suggests higher susceptibility of male patients for COVID-19 mortality and other acute viral infections compared to females. Analysis of severe acute respiratory syndrome coronavirus (SARS) and Middle East respiratory syndrome coronavirus (MERS) epidemiological data also indicate a gender-based preference in disease consequences. The current review addresses the possible mechanisms responsible for higher COVID-19 mortality among male patients. The major underlying aspects that was looked into includes smoking, genetic factors, and the impact of reproductive hormones on immune systems and inflammatory responses. Detailed investigations of this gender disparity could provide insight into the development of patient tailored therapeutic approach which would be helpful in improving the poor outcomes of COVID-19. Graphical abstract.


Sujet(s)
COVID-19/épidémiologie , Maladies cardiovasculaires/épidémiologie , Hypertension artérielle/épidémiologie , SARS-CoV-2/pathogénicité , Angiotensin-converting enzyme 2/génétique , COVID-19/complications , COVID-19/génétique , COVID-19/virologie , Maladies cardiovasculaires/complications , Maladies cardiovasculaires/génétique , Maladies cardiovasculaires/virologie , Diabète/épidémiologie , Diabète/génétique , Diabète/virologie , Femelle , Humains , Hypertension artérielle/complications , Hypertension artérielle/génétique , Hypertension artérielle/virologie , Mâle , Système rénine-angiotensine/génétique , Caractères sexuels
10.
Mol Biol Rep ; 47(11): 8499-8511, 2020 Nov.
Article de Anglais | MEDLINE | ID: mdl-33074411

RÉSUMÉ

Osteosarcoma is the most frequently occurring cancer in children as well as young adolescents and the metastatic forms worsen this condition to a further great extent. The metastatic dissemination of cancer cells is often acquired through a process of epithelial-mesenchymal transition (EMT). Since, phytochemicals have attracted intense interest in recent years due to their diverse pharmacological effects, in the present study, we investigated if berberine, a naturally occurring isoquinoline quaternary alkaloid, could modulate the EMT in osteosarcoma cells. Our experimental studies showed that berberine reduced cell viability, colony formation, wound healing ability and migration of osteosarcoma cells. Also, berberine significantly reduced the expression of matrix metalloproteinase (MMP)-2, suggesting its inhibitory action on the matrix metalloproteinases that are required for cancer cell invasion. The significant reduction in the expression of vimentin, N-cadherin, fibronectin and increased expression of E-cadherin further suggested its role in the inhibition of EMT in osteosarcoma cells. The downregulation of H3K27me3, as well as the decreased expression of the histone methyl transferase enzyme EZH2, further substantiated the fact that the plant alkaloid can be used as an epigenetic modulator in the treatment of osteosarcoma. In conclusion, our findings suggest that berberine inhibits proliferation and migration of osteosarcoma cells and most importantly reverses EMT along with modulation of key epigenetic regulators.


Sujet(s)
Berbérine/pharmacologie , Prolifération cellulaire/effets des médicaments et des substances chimiques , Transition épithélio-mésenchymateuse/effets des médicaments et des substances chimiques , Ostéosarcome/métabolisme , Cytosquelette d'actine/effets des médicaments et des substances chimiques , Cytosquelette d'actine/métabolisme , Cadhérines/génétique , Cadhérines/métabolisme , Lignée cellulaire tumorale , Mouvement cellulaire/effets des médicaments et des substances chimiques , Survie cellulaire/effets des médicaments et des substances chimiques , Épigenèse génétique/effets des médicaments et des substances chimiques , Transition épithélio-mésenchymateuse/génétique , Humains , Matrix metalloproteinase 2/métabolisme , Ostéosarcome/génétique , Ostéosarcome/anatomopathologie , Protéolyse/effets des médicaments et des substances chimiques , Vimentine/génétique , Vimentine/métabolisme , bêta-Caténine/génétique , bêta-Caténine/métabolisme
11.
J Fluoresc ; 30(6): 1553-1565, 2020 Dec.
Article de Anglais | MEDLINE | ID: mdl-32946027

RÉSUMÉ

Zinc is essential for growth and development of all living organisms, especially human being. Deficiency of micronutrients like zinc and iron has been linked to the manifestation of hidden hunger. Therefore, it is imperative that development of some rapid screening method for bioavailable zinc in various crops and food commodities would be an essential addition in battle against zinc deficiency related hidden hunger. One such method could be the usage of fluorescence based zinc ion sensing probe which would be robust and convenient for estimating bioavailable zinc. To address this issue, NBD-TPEA, a highly sensitive zinc ion sensing probe, have been used in this study towards the development of a novel fluorescence based approach for the analysis of zinc bioavailability in Caco-2 cells as an in-vitro cellular model. The use of this probe showed dose dependent sensitivity towards increasing concentrations of zinc ion uptake by Caco-2 cells. It also showed specificity for zinc ion uptake as compared to other metal ions in-vitro. These observations correlated extremely well with zinc uptake analysis by cell imaging and conventional analytical technique like, ICP-MS. The developed assay was then tested in mushroom and some selected biofortified derivatives of wheat for determining the levels of their bioavailable zinc using Caco-2 cells. The data as obtained with these food samples in our developed bioassay correlated well with the other sophisticated analytical techniques thus validating our cell based assay. Hence, the developed assay could serve as a simple but sensitive tool for determining bioavailable zinc in various food samples.


Sujet(s)
Colorants fluorescents/métabolisme , Zinc/métabolisme , Biodisponibilité , Transport biologique , Cellules Caco-2 , Humains , Limite de détection , Facteurs temps
12.
Dalton Trans ; 47(18): 6421-6434, 2018 May 08.
Article de Anglais | MEDLINE | ID: mdl-29687810

RÉSUMÉ

A compartmental chemosensor probe HL has been designed and synthesized for the selective recognition of zinc ions over other transition metal ions via fluorescence "ON" strategy. The chemosensing behaviour of HL was demonstrated through fluorescence, absorption and NMR spectroscopic techniques. The molecular structure of the zinc complex derived from HL was determined by X-ray crystallography. A probable mechanism of this selective sensing behavior was described on the basis of spectroscopic results and theoretical studies by density functional theory (DFT). The biological applicability of the chemosensor HL was examined via cell imaging on HeLa cells. The HL-zinc complex served as a secondary fluorescent probe responding to the pyrophosphate anion specifically over other anions. The fluorescence enhancement of HL in association with Zn2+ ions was quenched in the presence of pyrophosphate (PPi). Thus, a dual response was established based on "OFF-ON-OFF" strategy for detection of both cation and anion. This phenomenon was utilized in the construction of a "INHIBIT" logic gate.


Sujet(s)
Colorants fluorescents/composition chimique , Imagerie optique , Théorie quantique , Cristallographie aux rayons X , Diphosphates/composition chimique , Cellules HeLa , Humains , Concentration en ions d'hydrogène , Ions/composition chimique , Modèles moléculaires , Structure moléculaire , Spectrophotométrie UV , Cellules cancéreuses en culture , Zinc/composition chimique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...